• No results found

Interferon alpha-2b

Clinical Outcome of Topical Interferon Alpha 2b Cream in Phase II Trial for LSIL/CIN 1 Patients

Clinical Outcome of Topical Interferon Alpha 2b Cream in Phase II Trial for LSIL/CIN 1 Patients

... by Interferon alpha-2b Cream together with the tendency in favour of the treatment indicates that further investiga- tion into the efficacy of this therapeutic candidate in CIN 1/2 patients is ...

6

Response Surface Optimization of the Expression Conditions for Synthetic Human Interferon alpha-2b Gene in Escherichia coli

Response Surface Optimization of the Expression Conditions for Synthetic Human Interferon alpha-2b Gene in Escherichia coli

... provided predicted levels of rhIFNα2b activity (on mRNA expression level) as the function of the IPTG concentration (A), post induction period (B), and cell density (C) were calculated based on the equation obtained by ...

10

Effects of Interferon Alpha 2b on VEGFR 2, VEGFA, MAPK 1 and ERK 1 Gene Expression in Corneal Neovascularization Models

Effects of Interferon Alpha 2b on VEGFR 2, VEGFA, MAPK 1 and ERK 1 Gene Expression in Corneal Neovascularization Models

... of interferon alpha 2b on vascular endothelial growth factor receptor-2 (VEGFR-2), vascular endothelial growth factor-A (VEGFA), mitogen activated protein kinase-1 (MAPK-1) and extracellular signal ...

9

Design of an efficient medium for heterologous protein production in Yarrowia lipolytica: case of human interferon alpha 2b

Design of an efficient medium for heterologous protein production in Yarrowia lipolytica: case of human interferon alpha 2b

... human interferon a2b production in ...human interferon alpha 2b (hIFN a2b) production in a recombinant strain of ...a 2b production in a 5-l bioreactor in the optimal med- ium using ...

13

Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based review

Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based review

... defined. Interferon alpha-2b remains to date the most promising approach ...of interferon in its pegylated subcutaneous ...pegylated interferon alpha-2b in Stage III ...

10

Improvement in quality of life measures in patients with refractory hepatitis C, responding to re-treatment with Pegylated interferon alpha -2b and ribavirin

Improvement in quality of life measures in patients with refractory hepatitis C, responding to re-treatment with Pegylated interferon alpha -2b and ribavirin

... different interferon preparations and combination therapy with interferon and ...pegylated interferon with a slower rate of clearance and a longer half-life has improved the antiviral effects and has ...

8

TERT copy gain predicts the outcome of high-dose interferon α-2b therapy in acral melanoma

<em>TERT </em>copy gain predicts the outcome of high-dose interferon &alpha;-2b therapy in acral melanoma

... Given the mechanism by which IFN α -2b influences the growth of various cancer cells via the JAK/STAT and MAPK signal transduction pathways, some researchers have also found a relationship between TERT and these ...

8

Development of a cultivation process for the enhancement of human interferon alpha 2b production in the oleaginous yeast, Yarrowia lipolytica

Development of a cultivation process for the enhancement of human interferon alpha 2b production in the oleaginous yeast, Yarrowia lipolytica

... Human interferon a 2b (huIFN a 2b) production in Yarrowia lipolytica was used as a model for the enhancement of recombinant protein production under the control of the oleic acid (OA)-inducible ...

11

Improved Sustained Virological Response Following Treatment with Pegylated Interferon Alpha 2b Compared with Alpha 2a, Both with Ribavirin, for Chronic Hepatitis C Infection with Genotypes 2 and 3

Improved Sustained Virological Response Following Treatment with Pegylated Interferon Alpha 2b Compared with Alpha 2a, Both with Ribavirin, for Chronic Hepatitis C Infection with Genotypes 2 and 3

... With broadening of choices of therapy to include ge- notype specific direct acting antivirals (DAAs) [12,13] and the understanding that numerous host and viral fac- tors affect outcomes, choices affecting therapy are ...

7

Enabling low cost biopharmaceuticals: high level interferon alpha-2b production in Trichoderma reesei

Enabling low cost biopharmaceuticals: high level interferon alpha-2b production in Trichoderma reesei

... Production of fungal proteases has long been identi- fied as a significant barrier to achieving high production levels of heterologous proteins [15, 16]. In microbial pro- duction systems the protease problem has been ...

15

Overwhelming Postsplenectomy Infection for Splenectomized HCV Patients

Overwhelming Postsplenectomy Infection for Splenectomized HCV Patients

... 2007 Pegylated Interferon Alpha-2b plus Ribavirin in Patients with Genotype 4 Chronic Hepatitis C: The Role of Rapid and Early Virologic Response.. Di Bisceglie, A.M.[r] ...

5

Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis

Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis

... The pathogenesis of severe acute respiratory syndrome (SARS) remains unclear. Macrophages are key sentinel cells in the respiratory system, and it is therefore relevant to compare the responses of human macrophages to ...

8

Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6

Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6

... pegylated interferon alpha 2a or alpha 2b and ribavi- rin versus a usual palliative care for CHC genotype 1 were retrieved from a meta-analysis study [22] which in- cluded randomized ...

9

Pegylated interferon alpha 2a and  2b in combination with ribavirin in the treatment of chronic hepatitis C : a systematic review and economic evaluation

Pegylated interferon alpha 2a and 2b in combination with ribavirin in the treatment of chronic hepatitis C : a systematic review and economic evaluation

... Second, the choice of treatment method should be based on comparable costs between treatment arms. The incremental cost, that is, the difference in costs between one treatment method and another (i.e. the change in cost ...

148

Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer

Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer

... with interferon regulatory factor (IRF)-9 is termed interferon-stimulated gene factor-3 ...or interferon-stimulated response elements (ISREs) in DNA, respectively, transcribing ...

10

Differential expression of interferon induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha

Differential expression of interferon induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha

... IFN alpha was seen to induce changes in miRNA expression in patients with CHC, and that the highest increase in each miRNA was seen only in responder patients, no significant differences were found in the ...

9

Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects

Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects

... SHP-1 is a critical negative regulator in anti-tumor immune cells that include T cells [37], NK cells [38], dendrocytes and macrophages [39]. Importantly, the PTP controls T cell activation [40] by reducing the ...

10

Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil

Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil

... peginterferon-alfa 2b, dosage is based on patient’s weight ...peginterferon-alfa 2b SPC (summary of product characteristics), we have considered that unused portion of drug was ...peginterferon-alfa ...

9

Melanoma treatment in review

Melanoma treatment in review

... – interferon α-2b/peginterferon α-2b, interleukin-2, ontak, ipilimumab, nivolumab, pembrolizumab, and talimogene laherparepvec) or in trials (in gray – durvalumab, CK-301, avelumab, atezolizumab, ...

15

Recognition of herpesviruses by the innate immune system

Recognition of herpesviruses by the innate immune system

...  Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection.. Alpha/Beta interferon and gamma interferon synergiz[r] ...

42

Show all 9115 documents...

Related subjects